the aid library

LIST OPTIONS

Filter

8587

Download (784)

View PDF (2033)

WHO Sierra Leone 2016 - 2017: From Ebola to Health

World Health Organization (WHO) (2017) C_WHO

External Link

Laboratory techniques in rabies

Rupprecht, C.; Fooks, A,; Abela-Ridder, B. World Health Organization WHO (2018) C_WHO

Rabies has an enormous impact on both agriculture and conservation biology, but its greatest burden is undeniably on public health. As such, routine methods for rapid risk assessment after human exposures to rabies as well as applications for laboratory-based surveillance, production of biologicals ... more

Download (602)

View PDF (958)

HIV/AIDS in Ethiopia

MEASURE DHS (2013) C2

Data from the 2011 Ethiopia Demographic and Health Survey

Download (628)

View PDF (770)

India: TRAINING OF Link ART Centre (LAC) COUNSELLORS - HANDBOOK FOR TRAINEES

National AIDS Control Organization (NACO), Ministry of Health and Family Welfare, Government of India (2012) C1

Download (2912)

View PDF (1787)

Rwanda: GYNECOLOGY AND OBSTETRICS CLINICAL PROTOCOLS & TREATMENT GUIDELINES

Ministry of Health, Rwanda (2012) C2

The guidelines presented in this document are designed to provide a useful resource for healthcare professionals involved in clinical case management. They were developed taking into consideration services provided at different levels within the health system and resources available. These guideline... more

Download (477)

View PDF (449)

A position statement and practical guide to the use of particulate filtering facepiece respirators (N95, FFP2, or equivalent) for South African health workers exposed to respiratory pathogens includin

Dheda, K.; et al. (2022) CC

Afr J Thoracic Crit Care Med 2021;27(4):Published online 22 October 2021. https://doi.org/10.7196/AJTCCM.2021.v27i4.173

External Link

MSF الإرشادات السريرية. دليل التشخيص والعلاج
recommended

Médecins sans Frontières (MSF) (2022) C2

Clinical Guidelines. Diagnosis and Treatment Manual.

Download (1103)

View PDF (1949)

Uganda: Manual for management and control of tuberculosis and leprosy
recommended

Ministry of Health, Republic of Uganda (2017) C2

UGANDA NATIONAL TUBERCULOSIS AND LEPROSY CONTROL PROGRAMME

Download (1400)

View PDF (620)

Primary Surgery Vol. One: Non-Trauma
recommended

Cotton, M., et al. Global Healp; Deutsche Gesellschaft für Tropenchirurgie; International Coll. Essential Surgery (2016) CC

This comprehensive book has established itself as the most useful text for the medical practitioner in poor-resource settings who is obliged to manage surgical cases. It is particularly adapted for those whose surgical experience is basic or minimal. Importantly, it has extensive advice about pitfal... more

Download (6153)

View PDF (17280)

MSF Clinical Guidelines. Diagnosis and Treatment Manual
recommended

Médecins sans Frontières (MSF) (2022) C2

This diagnostic and treatment manual is designed for use by medical professionals involved in curative care at the dispensary and hospital levels. We have tried to respond in the simplest and most practical way possible to the questions and problems faced by field medical staff, using the accumulate... more

Download (702)

View PDF (873)

Interim National Guidelines for Monkeypox Outbreak Response

Federal Ministry of Health - Nigeria Centre for Disease Contro (2017) C2

This document provides information and recommendations for action, based on the current available knowledge around monkeypox. It is a first draft which will be updated in light of evolving evidence and additional information as they become available.

Download (359)

View PDF (313)

WHO policy brief: COVID-19 testing, 14 September 2022

World Health Organization WHO (2022) C_WHO

The World Health Organization (WHO) recognizes the challenges countries face for maintaining their COVID-19 response while addressing competing public health challenges, conflicts, climate change and economic crises. It remains critical for national programmes to continue to offer testing for COVI... more

Download (651)

View PDF (1313)

Clinical Protocol for the Health & Development of Adolescent and Young people in Nigeria

Federal Ministry of Health, Nigeria; WHO; UNFPA (2011) C_WHO

Download (689)

View PDF (913)

HIV Prevalence and Associated Risk Factors: Analysis of Change Over Time in Mainland Tanzania

Mmbaga, Elia John ICF International (2013) C2

DHS Working Papers No. 85

Download (577)

View PDF (1528)

Haiti: Cholera figures (18 November 2016)

UN Office for the Coordination of Humanitarian Affairs (2016) C1

This document summarizes Haiti's cholera situation as of November 16, 2016. Between January and October 2016, Haiti reported 35,203 new suspected cholera cases (32% increase from 2015) and 369 deaths (56% increase). After Hurricane Matthew, cases rose dramatically, with 52% of new cases concentrated... more

Download (607)

View PDF (790)

Therapeutics and COVID-19 (Living Guideline, 10 November 2023)

World Health Organization WHO (2023) C_WHO

WHO has updated its guidelines for COVID-19 therapeutics, with revised recommendations for patients with non-severe COVID-19. This is the 13th update to these guidelines. Updated risk rates for hospital admission in patients with non-severe COVID-19 The guidance includes updated risk rates for... hospital admission in patients with non-severe COVID-19. The current COVID-19 virus variants tend to cause less severe disease while immunity levels are higher due to vaccination, leading to lower risks of severe illness and death for most patients. This update includes new baseline risk estimates for hospital admission in patients with non-severe COVID-19. The new ‘moderate risk’ category now includes people previously considered to be high risk including older people and/or those with chronic conditions, disabilities, and comorbidities of chronic disease. The updated risk estimates will assist healthcare professionals to identify individuals at high, moderate or low risk of hospital admission, and to tailor treatment according to WHO guidelines: **High: **People who are immunosuppressed remain at higher risk if they contract COVID-19, with an estimated hospitalization rate of 6%. **Moderate: **People over 65 years old, those with conditions like obesity, diabetes and/or chronic conditions including chronic obstructive pulmonary disease, kidney or liver disease, cancer, people with disabilities and those with comorbidities of chronic disease are at moderate risk, with an estimated hospitalization rate of 3%. Low: Those who are not in the high or moderate risk categories are at low risk of hospitalization (0.5%). Most people are low risk. Review of COVID-19 treatments for people with non-severe COVID-19 WHO continues to strongly recommend nirmatrelvir-ritonavir (also known by its brand name ‘Paxlovid’) for people at high-risk and moderate risk of hospitalization. The recommendations state that nirmatrelvir-ritonavir is considered the best choice for most eligible patients, given its therapeutic benefits, ease of administration and fewer concerns about potential harms. Nirmatrelvir-ritonavir was first recommended by WHO in April 2022. If nirmatrelvir-ritonavir is not available to patients at high-risk of hospitalization, WHO suggests the use of molnupiravir or remdesivir instead. WHO suggests against the use of molnupiravir and remdesivir for patients at moderate risk, judging the potential harms to outweigh the limited benefits in patients at moderate risk of hospital admission. For people at low risk of hospitalization, WHO does not recommend any antiviral therapy. Symptoms like fever and pain can continue to be managed with analgesics like paracetamol. WHO also recommends against use of a new antiviral (VV116) for patients, except in clinical trials. The update also includes a strong recommendation against the use of ivermectin for patients with non-severe COVID-19. WHO continues to advise that in patients with severe or critical COVID-19, ivermectin should only be used in clinical trials. more